SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
652Usually the purpose of an authorized generic is to capture part of the excess prBiomaven-2/13/2007
651<i>But I'm not sure it makes sense for sanofi to do that unless there DewDiligence_on_SI-2/13/2007
650I stand by the assertion in message #641. Here’s the relevant passage from todayDewDiligence_on_SI-2/13/2007
649How come no one asked about the share price taking a dirt nap on the CC? Larry Go Market Go!-2/13/2007
648>> If SNY were to launch an authorized generic for Lovenox, the economics IRWIN JAMES FRANKEL-2/13/2007
647<i>As far as I know they won't discuss the patent challenge angle.<DewDiligence_on_SI-2/13/2007
646As far as I know they won't discuss the patent challenge angle. Probably wilrkrw-2/13/2007
645What is the MNTA/NVS patent angle on Copaxone? It’s nominally protected until 20DewDiligence_on_SI-2/13/2007
644Call it a hunch, but I expect the copaxone anda will be filed this year.rkrw-2/13/2007
643That's a potentially costly flaw in the mnta lovenox deal. imo. But I'rkrw-2/13/2007
642Dew notes --surprise, surprise -- that Sanofi will appeal the recent Lovenox dectuck-2/13/2007
641If SNY were to launch an authorized generic for Lovenox, the economics received DewDiligence_on_SI-2/13/2007
640From their c/c: ``We believe that 2007 has the potential to become a transformadr.praveen-2/13/2007
639M118 will enter phase-2a in 2H07 in angioplasty for stable angina. (Source: TodaDewDiligence_on_SI-2/13/2007
638Quite a long standing parade of insider sellers, including one just last week atBio-Newbie-2/12/2007
637New Form 4 from Thur for 30K shares at 21 per YMB. Have not looked yet. JonRobohogs-2/12/2007
636Thanks for letting me off the hook :-) 144's should slow down a little arkrw-2/12/2007
635>>Breakout was in the same huge ballroom with a mike in the middle. I was tuck-2/12/2007
634Breakout was in the same huge ballroom with a mike in the middle. I was way off rkrw-2/12/2007
633"I skipped the webcast and went in person :-) . . . He was also atuck-2/12/2007
632I skipped the webcast and went in person :-) CEO is bold. Says review going wrkrw-2/12/2007
631they slipped up, and let one of the forward-sales blocks show, wrong time? wasnscaram(o)uche-2/12/2007
630DD - you should be in Grand Cayman, I heard it all. :-) No comment on the quicIRWIN JAMES FRANKEL-2/12/2007
629Replay shows presentation running out at beginning of Q&A. They intentionallfred hayes-2/12/2007
628My webcast line dropped out at the start of the Q&A. Anyone else have the saDewDiligence_on_SI-2/12/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News